PDCD1 and neoplasm: Furthermore, we observed a significant decrease in the frequency of PD1+ CD4+ cells in the spleen (Supplementary Figure 11C), as well as a decrease in PDL1 expression in tumor cells (Figure 4F), suggesting strongly that the vaccination protocol had overcome the T-lymphocyte anergy.